The role of testosterone in menopausal hormone treatment. What is the evidence?

@article{Johansen2020TheRO,
  title={The role of testosterone in menopausal hormone treatment. What is the evidence?},
  author={Nora Johansen and Angelica Lind{\'e}n Hirschberg and Mette Haase Moen},
  journal={Acta Obstetricia et Gynecologica Scandinavica},
  year={2020},
  volume={99},
  pages={966 - 969}
}
About 40% of postmenopausal women have decreased sexual desire, causing distress. Estrogen therapy attenuates vaginal complaints but has no effect on sexual desire. Although sexual function has been linked to testosterone, there is no clear relation between sexual desire and circulating levels of testosterone. Nevertheless, treatment with transdermal (patch) testosterone improved sexual function in several randomized controlled trials. Women with hypoactive sexual desire disorder who were… 
2 Citations
Global consensus statement on testosterone therapy for women: an Australian perspective
TLDR
The 2019 global consensus position statement on the use of testosterone therapy for women aims to provide guidance for clinicians managing women with female sexual dysfunction and bases many of its recommendations on a systematic review and metaanalysis of randomised controlled trials.
Multifaceted Sexual Dysfunction in Dialyzing Men and Women: Pathophysiology, Diagnostics, and Therapeutics
TLDR
The pathophysiological and the psychosocial causes of SD with regard to renal replacement therapy, particularly hemo- and peritoneal dialysis and the impact of comorbidities and the iatrogenic causes are described.

References

SHOWING 1-10 OF 30 REFERENCES
Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
TLDR
In the Intimate SM 1 study, the testosterone patch improved sexual function and decreased distress in surgically menopausal women with HSDD and was well tolerated in this trial.
Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study
TLDR
Testosterone patch treatment increased the frequency of satisfying sexual activity and sexual desire, decreased personal distress, and was well tolerated in naturally menopausal women with hypoactive sexual desire disorder.
Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial
TLDR
Transdermal testosterone therapy via a skin patch improved sexual desire and other sexual function domains and was well tolerated in these oophorectomized women with HSDD receiving concomitant transdermal estrogen.
Testosterone Patch for Low Sexual Desire in Surgically Menopausal Women: A Randomized Trial
TLDR
In surgically menopausal women with hypoactive sexual desire disorder, a 300 μg/d testosterone patch significantly increased satisfying sexual activity and sexual desire, while decreasing personal distress, and was well tolerated through up to 24 weeks of use.
Is there a correlation between androgens and sexual desire in women?
TLDR
Sexual desire correlated overall with FT and androstenedione in the total cohort of women and ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgen levels by mass spectrometry.
Testosterone in women--the clinical significance.
TLDR
Clinical trials suggest that exogenous testosterone enhances cognitive performance and improves musculoskeletal health in postmenopausal women and unmet needs include the availability of approved testosterone formulations for women and studies to elucidate the contribution of testosterone to cardiovascular, cognitive, and musculosity health and the risk of cancer.
Testosterone for low libido in postmenopausal women not taking estrogen.
TLDR
In postmenopausal women not receiving estrogen therapy, treatment with a patch delivering 300 microg of testosterone per day resulted in a modest but meaningful improvement in sexual function.
Safety and Efficacy of a Testosterone Patch for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women: A Randomized, Placebo-Controlled Trial
TLDR
The 300-μg/d testosterone patch increased sexual desire and frequency of satisfying sexual activity and was well tolerated in women who developed hypoactive sexual desire disorder after surgical menopause.
Testosterone treatment of HSDD in naturally menopausal women: the ADORE study
TLDR
TTP was effective in treating HSDD and improving sexual function in this study of naturally menopausal women with and without concurrent hormone therapy.
A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal women
TLDR
A concise and critical summary of the literature is provided, to guide clinicians treating postmenopausal women about the pathophysiological role of testosterone during the menopause.
...
1
2
3
...